TOFACIB® (tofacitinib) is an ointment for topical use, which proven to work for alopecia areata.

The studies conducted demonstrated breakthrough therapy of tofacitinib for the treatment of an alopecia areata.

In 70% of cases, TOFACIB is able to restore hair in patients suffering from alopecia areata, the duration of therapy is 24 weeks and can be extended at your doctor’s discretion.

*You are kindly asked to assess your risks in advance and to realize the 30% of unsuccessful therapy. Please, do not start the therapy and do not purchase TOFACIB® if the percentage specified doesn’t suit you.

Now may be the time to put ALOPECIA behind you.

Subscribe to Our Newsletter

When you sing up to our newsletter, you will be the first to learn about promotions, special events, and news.

Required field Incorrect Email
You have successfully subscribed to the newsletter
You could not subscribe to the newsletter
You are already subscribed to this newsletter

Please Consult With Your Healthcare Provider Before Apply TOFACIB

Important Safety Information:

Contraindications:

Heavy hepatic impairment, infection induced by В and/or C hepatitis viruses (presence of infection Serological markers HBV and HCV), creatinine clearance less than 40 ml/min, concurrent administration of attenuated vaccines. Severe infections, active infections, including local. Pregnancy (no studies carried out in terms of safety and efficacy). Breast-feeding period. Childhood and age under 18 (no studies carried out in terms of safety and efficacy). Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

Inform your doctor if:

You think you have infection or symptoms of infection, such as fever, excessive sweat or shivering attack; cough; blood in sputum; erethistic ulcer on skin; urethral burning; muscle pain; labored breathing; body weight loss; diarrhea or abdominal pain, or strong fatigue.

Common Side Effects:

Rash, itch, headache, fatigue.